Actavis signs preliminary deal to sell Western European businesses to Aurobindo; finalized
Executive Summary
The European division of Indian generic drug and API manufacturer Aurobindo Pharma Ltd. signed a preliminary agreement to acquire Actavis PLC’s businesses in seven Western European countries: France, Italy, Spain, Portugal, Belgium, Germany, and the Netherlands. The sale is contingent upon antitrust approvals and completion of employee consultation processes. Depending on Aurobindo’s cash and net working capital at the time the transaction is finalized, the purchase price could be €30mm ($41mm).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash for Equity
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice